ABCL   $3.04  -7.32% Market Closed

Abcellera Biologics Inc
Total Cash 643.14M
totalCashPerShare 2.179
EBITDA -222.24M
Total Debt 66.27M
quickRatio 8.477
currentRatio 9.336
Total Revenue 32.96M
debtToEquity 6.147
Revenue/Share 0.112
ROA -0.13256
ROE -0.15551
grossProfits
freeCashflow -105.07M
operatingCashflow -120.17M
earningsGrowth
revenueGrowth -0.014
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -14.39419
profitMargins 0.0
enterpriseValue 225.96M
forwardPE -3.887324
floatShares 188.87M
sharesOutstanding 295.37M
sharesShort 17.35M
sharesShortPriorMonth 16.84M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.38%
Short Ratio help_outline 10.12%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 3.653
Price To Book help_outline 0.76
earningsQuarterlyGrowth
netIncomeToCommon -175.80M
trailingEps -0.61%
forwardEps -0.71%
enterpriseToEbitda -1.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 4Q 2024
institutionsCount 213
lastUpdated Nov. 7, 2024, 3:30 a.m.